Researchers are continually working on new innovations that could bring something positive to Alzheimer's care. Now, according to the American Chemical Society, there could be a way to reduce inflammation in the brain cells of patients with the disease.
Researchers are pointing to a potential new oral drug that could help reduce inflammation in an Alzheimer's brain. The study's authors looked at compounds that had a similar molecular architecture to Minozac, a drug in clinical trials that could fight brain cell destruction. After reviewing these compounds the researchers suggest that they could help in relieving inflammation, and were already found to improve memory and learning in mice models.
"In general, this study not only proves that countering neuroinflammation is indeed a potential therapeutic strategy for Alzheimer's disease, but also provides a good lead compound with efficacy comparable to donepezil [an existing Alzheimer's disease medicine] for further oral anti-Alzheimer's disease drug discovery and development," the report states.
Alzheimer's disease is one of the top causes of death in the United States, and the only one that cannot be cured or even slowed in progression, according to the Alzheimer's Association.
Residential Home Health is a leading provider of in-home nursing and therapy care throughout Michigan and Illinois. In addition to home health care, Residential’s continuum of care includes Residential Hospice and Healthy Living Medical Supply. If you are interested in learning more about the home care services Residential provides, please call 866-902-4000 or visit www.residentialhomehealth.com.